Filtros de búsqueda

Lista de obras de Patricia Bourguignon

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

artículo científico publicado en 2015

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

artículo científico publicado en 2011

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers ⬇️

artículo científico publicado el 5 de enero de 2011

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

artículo científico publicado en 2014

Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine

scientific article published on 03 January 2014

Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen

artículo científico publicado en 2008

Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults

artículo científico publicado en 2013

Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.

artículo científico publicado en 2012

Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients

artículo científico publicado en 2014

Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study

artículo científico publicado en 2013

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

artículo científico publicado en 2016

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

artículo científico publicado en 2010

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.

artículo científico publicado en 2016

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques ⬇️

artículo científico publicado el 16 de septiembre de 2012

Vaccine-induced HIV seropositivity: A problem on the rise ⬇️

artículo científico publicado el 1 de abril de 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda